Conjunctivitis - 119 Studies Found
| Completed |
: Topical Tacrolimus in Vernal Keratoconjunctivitis : Vernal Keratoconjunctivitis : 2013-08-18 : Drug: Topical tacrolimus Topical tacrolimus 0.01% twice daily for one month |
| Completed |
: Topical Cyclosporine for Vernal Keratoconjunctivitis (VKC) in Rwanda : Vernal Keratoconjunctivitis : 2010-09-28 :
|
| Completed |
: Phase 3 Study of OTX-101 in the Treatment of Keratoconjunctivitis Sicca : Keratoconjunctivitis Sicca : 2016-02-13 :
|
| Enrolling by invitation |
: An Open-Label Extension of a Phase 3 Study of OTX-101 in the Treatment of Keratoconjunctivitis Sicca : Keratoconjunctivitis Sicca : 2016-07-24 : Drug: OTX-101 0.09% 0.09% cyclosporine nanomicellar solution |
| Completed |
: Study of the Clinical and Biological Efficacity of NAAXIA SINE® in Vernal Keratoconjunctivitis : Keratoconjunctivitis, Vernal : 2006-07-26 : Drug: N-acetyl-aspartyl-glutamate (NAAXIA Sine) |
| Completed |
: Lotemax® Gel 0.5% and Restasis 0.05% in Subjects With Mild or Moderate Keratoconjunctivitis Sicca : Keratoconjunctivitis Sicca : 2013-03-21 :
|
| Completed |
: To Assess the Safety and Efficacy of R932348 Ophthalmic Solutions in Patients With Keratoconjunctivitis Sicca : Keratoconjunctivitis Sicca : 2013-07-11 :
|
| Completed |
: A Dose-Escalation Study to Assess the Safety and Tolerability of LX214 Ophthalmic Solution in Healthy Volunteers, Followed by an Open-Label Evaluation of LX214 in Patients With Keratoconjunctivitis Sicca (KCS) : Keratoconjunctivitis Sicca : 2009-02-24 : Drug: voclosporin ophthalmic solution 0.02%, 0.2% t.i.d. or b.i.d. |
| Completed |
: Phase III Study of 0.1% Tacrolimus(FK506) Ophthalmic Suspension in Patients With Vernal Keratoconjunctivitis :
: 2007-12-03 :
|
| Completed |
: Effects of Conventional Dry Eye Treatments on the Ocular Surface Response to Low Humidity Environment in Patients With Keratoconjunctivitis Sicca :
: 2013-02-21 : Drug: dexamethasone, artificial tears |